Yuh‐Jyh Jong

National Yang Ming Chiao Tung University — Taiwan

Medicine · Health Sciences

44h-index7.6kcitations256works4.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Neurogenetic and Muscular Disorders Research(79), RNA modifications and cancer(48), Muscle Physiology and Disorders(45), Metabolism and Genetic Disorders(21), Congenital Anomalies and Fetal Surgery(19)

Publications256 total

Intrathecal onasemnogene abeparvovec in treatment-naive patients with spinal muscular atrophy: a phase 3, randomized controlled trial
Nature Medicine·2025· 3 citedOpen Access
The Taiwan Precision Medicine Initiative provides a cohort for large-scale studies
Nature·2025· 8 citedOpen Access
344PNeuropathy associated with activated Bcl2/apoptosis pathway in a new mouse model of multiple acyl-coenzyme a dehydrogenase deficiency (MADD)
Neuromuscular Disorders·2025
415PIntrathecal onasemnogene abeparvovec for patients with spinal muscular atrophy: phase 3, randomized, sham-controlled, double-blind STEER study
Neuromuscular Disorders·2025· 1 cited
Confirmatory long-term efficacy and safety results of ataluren in patients with nmDMD from Study 041, an international, randomized, double-blind, placebo-controlled, Phase III trial
Journal of Comparative Effectiveness Research·2025Open Access
Effort-independent respiratory monitoring in Duchenne muscular dystrophy: clinical value of impulse oscillometry
European Journal of Pediatrics·2025
Newborn screening facilitates early theranostics and improved spinal muscular atrophy outcome: five-year real-world evidence from Taiwan
Orphanet Journal of Rare Diseases·2025· 3 citedOpen Access
Treating neuromuscular diseases: unveiling gene therapy breakthroughs and pioneering future applications
Journal of Biomedical Science·2025· 19 citedOpen Access
Polygenic height prediction for the Han Chinese in Taiwan
npj Genomic Medicine·2025· 1 citedOpen Access
Optimizing DMD management in Asia: Current challenges and future directions
Journal of Neuromuscular Diseases·2025Open Access
Safety and Efficacy of IV Onasemnogene Abeparvovec for Pediatric Patients With Spinal Muscular Atrophy
Neurology·2024· 15 citedOpen Access
ETFDH mutation involves excessive apoptosis and neurite outgrowth defect via Bcl2 pathway
Scientific Reports·2024· 1 citedOpen Access
The Taiwan Precision Medicine Initiative: A Cohort for Large-Scale Studies
2024· 5 citedOpen Access
Creatine and l-carnitine attenuate muscular laminopathy in the LMNA mutation transgenic zebrafish
Scientific Reports·2024· 5 citedOpen Access
Ataluren Slows the Decline of Muscle Function in Patents with nmDMD: A Meta-analysis of Three Randomized, Double-blind, Placebo-controlled Trials (P3-11.002)
Neurology·2024
RWD164 The Impact of Spinal Muscular Atrophy (SMA) Type 1 on Caregivers in Taiwan: Results of a Global Survey
Value in Health·2023Open Access
Ataluren Preserves Muscle Function in nmDMD Patients: A Pooled Analysis of Results from Three Randomized, Double-Blind, Placebo-Controlled Trials
Neuropediatrics·2023
Creatine and L-carnitine attenuate muscular laminopathy in the LMNA mutation transgenic zebrafish
Research Square (Research Square)·2023Open Access
P353 ETFDH mutation causes excessive apoptosis and neurite outgrowth defect via Bcl2 pathway
Neuromuscular Disorders·2023
Continued benefit of nusinersen initiated in the presymptomatic stage of spinal muscular atrophy: 5‐year update of the<scp>NURTURE</scp>study
Muscle & Nerve·2023· 100 citedOpen Access
page 1 of 13Next →

Frequent Co-authors

Jan‐Gowth Chang(8), Wen‐Chen Liang(8), Wuh‐Liang Hwu(6), Hsien‐Da Huang(5), Ichizo Nishino(5), Enrico Bertini(4), Richard S. Finkel(4), Janbernd Kirschner(4), Haluk Topaloğlu(4), Shun‐Fa Yang(4), Chih‐Hsing Hung(4), San‐Nan Yang(4), Nancy L. Kuntz(3), Russell J. Butterfield(3), Shinn‐Ying Ho(3), Chien‐Ning Huang(3), Yin‐Hsiu Chien(3), Ni‐Chung Lee(3), Wang‐Tso Lee(3), Yi‐Ching Lo(3)